Calculated
DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
43.48 USD40.64 USD50.96 USD
+646%
40.64 USDCurrent price is 646.3% above the base model value.
A
HealthcareBiotechnologyUnited States
ALNY.US · Alnylam Pharmaceuticals, Inc.
NMS · US · USD
Latest price303.30 USD
30D+4.52%
Vs. base value+646%
Research summary
ALNY.US latest organized financial period shows revenue lacks a complete YoY comparison and net income grew +55.16% YoY. Current price is about 303 USD, while the model base case is about 40.64 USD; the current price sits +646% versus the base case. This summary is intended for public-information research and model review.
Key financial trend
Annual financial metrics with switchable views. · Unit: USD
Revenue-
Net income314M USD
Free cash flow465M USD
Operating cash flow524M USD
Price trend
Price date: 2026/04/28 · Updated: 2026/04/29 07:21
Valuation model range
Hover each model row to inspect formulas and inputs.
Current price303.30 USD
Base value40.64 USD
Vs. base+646%
Price date2026/04/28
43.48 USD40.64 USD50.96 USD
+646%
Calculated
Owner Earnings
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
47.12 USD76.22 USD99.32 USD
+298%
76.22 USDCurrent price is 297.9% above the base model value.
Calculated
Reverse DCF
Solves the forward FCF growth rate implied by the current price.
Implied growth24.6%
Current price implies roughly 24.6% annualized FCF growth.
24.6%Current price implies roughly 24.6% annualized FCF growth.
Calculated
Earnings Power Value
Estimates earnings power value without assuming growth.
32.70 USD32.70 USD32.70 USD
+828%
32.70 USDCurrent price is 827.6% above the base model value.
Updated: 2026/04/29 07:21
Ad placement
Quarterly and annual financial table
Financial DetailsShowing latest 5 / 10
| Period | Type | Revenue | Net Income | Free Cash Flow | Diluted EPS |
|---|---|---|---|---|---|
| 2025/12/30 | Annual | - | 314M USD | 465M USD | 2.33 |
| 2025/09/29 | Annual | - | 202M USD | - | 1.51 |
| 2025/06/29 | Annual | - | -90M USD | - | -0.7 |
| 2024/12/30 | Annual | - | -278M USD | -43M USD | -2.18 |
| 2023/12/30 | Annual | - | -440M USD | 42M USD | -3.52 |
Ad placement